Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Designing Impactful Warnings for Sugary Drinks

22 janvier 2021 mis à jour par: University of North Carolina, Chapel Hill

The goal of this online RCT study is to examine how sugar-sweetened beverage (SSB) health warnings influence US adults' perceptions and reactions. The investigators have the following predictions:

  1. SSB warnings will be perceived as more effective than the control (message topic)
  2. Icon and graphic warnings will be perceived as more effective than text-only warnings (message type)

The investigators will also examine the interaction of warning topic and warning type, but have no specific hypothesis about this interaction.

Finally, the investigators will test the following predictions about the secondary outcomes:

SSB warnings (vs. control), as well as icon and graphic warnings (vs text.warnings), will lead to lower perceived product healthfulness, lower purchase intentions, and higher cognitive elaboration.

Aperçu de l'étude

Description détaillée

Childhood obesity is a major public health problem in the US among racial and ethnic minorities, including among the US's growing Latino population. One promising but understudied policy for addressing childhood obesity is requiring warnings on the front of sugar-sweetened beverage containers. However, the topic and design of warnings that are most effective in communicating the harms of sugar-sweetened beverages remains unknown. This study assess which warning topics and which warning designs lead to the greatest perceived message effectiveness among US Latino and non-Latino parents of children ages 2-12. The investigators focus on parents as they are the primary decision-makers and purchasers of food products for children and exert strong influence over their children's dietary intake and food attitudes.

Setting: The trial will take place online on a survey developed using Qualtrics.

Recruitment: Participants will be recruited online by CloudResearch PrimePanels, a survey research platform with access to over 20 million participants. As such, participants will have to be PrimePanels members in order to participate.

Informed Consent: After determining eligibility, eligible participants will be directed to a page on Qualtrics with the consent form. Participants acknowledge their consent in the study by clicking the "next page" arrow and proceeding to the study.

Randomization: After consenting, the participant is randomly assigned to to view one of the 5 warning topics. "WARNING: High in added sugar" (added sugar), "WARNING: Excess consumption of drinks with added sugar contributes to weight gain" (weight gain), "WARNING: Excess consumption of drinks with added sugar contributes to type 2 diabetes" (Type 2 diabetes), "WARNING: Excess consumption of drinks with added sugar contributes to heart damage" (heart damage), and "Please refrain from littering" (control). Within each of the four experimental arms, participants see the message displayed on four different types of warning designs: a text warning on a square background, a text warning on a octagon background, and icon warning, and a graphic warning. Within the control arm, participants see the message displayed on three different types of warning designs: a text warning on a square background, an icon warning, and a graphic warning. Participants randomly see the different warning designs in a random order.

Survey: The participants complete a survey answering behavioral perceptions and intentions questions about the different warning labels.

Type d'étude

Interventionnel

Inscription (Réel)

1078

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • North Carolina
      • Chapel Hill, North Carolina, États-Unis, 27599
        • University of North Carolina Chapel Hill

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 99 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • at least 18 years old
  • Prime Panels member
  • have at least one child ages 2-12
  • Currently reside in the US

Exclusion Criteria:

  • less than 18 years old

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Added sugar warning message
Message displayed on warning labels is: "WARNING: High in added sugar."
The warning message is in white text on a black square background
The warning message is in white text on a black octagon background
The warning message in in white text on a black background, below an icon that conveys the topic the warning is about
The warning message in in white text on a black background, below a graphic that conveys the topic the warning is about
Expérimental: Weight gain warning message
Message displayed on warning labels is: "WARNING: Excess consumption of drinks with added sugar contributes to weight gain."
The warning message is in white text on a black square background
The warning message is in white text on a black octagon background
The warning message in in white text on a black background, below an icon that conveys the topic the warning is about
The warning message in in white text on a black background, below a graphic that conveys the topic the warning is about
Expérimental: Type 2 diabetes warning message
Message displayed on warning labels is: "WARNING: Excess consumption of drinks with added sugar contributes to type 2 diabetes."
The warning message is in white text on a black square background
The warning message is in white text on a black octagon background
The warning message in in white text on a black background, below an icon that conveys the topic the warning is about
The warning message in in white text on a black background, below a graphic that conveys the topic the warning is about
Expérimental: Heart damage warning message
Message displayed on warning labels is: "WARNING: Excess consumption of drinks with added sugar contributes to heart damage."
The warning message is in white text on a black square background
The warning message is in white text on a black octagon background
The warning message in in white text on a black background, below an icon that conveys the topic the warning is about
The warning message in in white text on a black background, below a graphic that conveys the topic the warning is about
Comparateur actif: Neutral message
Message displayed on control label is: "Please refrain from littering."
The warning message is in white text on a black square background
The warning message in in white text on a black background, below an icon that conveys the topic the warning is about
The warning message in in white text on a black background, below a graphic that conveys the topic the warning is about

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Perceived message effectiveness
Délai: During survey, which lasts approximately 12-15 minutes.

Perceived message effectiveness as measured by average response to three statements:

This message makes me concerned about the health effects of drinking beverages with added sugar. Response options are on a scale (1=Strongly disagree...5=Strongly agree).

This message makes drinking beverages with added sugar seem unpleasant to me. Response options are on a scale (1=Strongly disagree...5=Strongly agree).

This message discourages me from wanting to drink beverages with added sugar. Response options are on a scale (1=Strongly disagree...5=Strongly agree).

During survey, which lasts approximately 12-15 minutes.

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Perceived product healthfulness of beverages with added sugar
Délai: During survey, which lasts approximately 12-15 minutes.
Measured with the question, "How healthy or unhealthy would it be for your child to drink beverages with added sugar every day?" Response options are on a scale (1= Very unhealthy...5=Very healthy).
During survey, which lasts approximately 12-15 minutes.
Intentions to purchase beverages with added sugar
Délai: During survey, which lasts approximately 12-15 minutes.
Measured with the question, "How likely are you to buy beverages with added sugar for your child in the next four weeks?" Response options are on a scale (1 = Not at all likely...5 = Extremely likely).
During survey, which lasts approximately 12-15 minutes.
Thinking about the health problems from beverages with added sugar
Délai: During survey, which lasts approximately 12-15 minutes.
Measured with the question, "How much does this message make you think about the health problems caused by drinking beverages with added sugar?" Response options are on a scale (1=Not at all...5=Very much).
During survey, which lasts approximately 12-15 minutes.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Marissa G Hall, PhD, University of North Carolina

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

7 octobre 2019

Achèvement primaire (Réel)

4 novembre 2019

Achèvement de l'étude (Réel)

4 novembre 2019

Dates d'inscription aux études

Première soumission

6 mai 2020

Première soumission répondant aux critères de contrôle qualité

6 mai 2020

Première publication (Réel)

11 mai 2020

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

25 janvier 2021

Dernière mise à jour soumise répondant aux critères de contrôle qualité

22 janvier 2021

Dernière vérification

1 janvier 2021

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 19-0277a

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner